Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Metformin for weight control in pediatric patients on atypical antipsychotic medication.

Shin L, Bregman H, Breeze JL, Noyes N, Frazier JA.

J Child Adolesc Psychopharmacol. 2009 Jun;19(3):275-9. doi: 10.1089/cap.2008.094.

PMID:
19519262
2.
3.

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.

Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, He YQ, Liu YJ, Chen JD, Li LH.

JAMA. 2008 Jan 9;299(2):185-93. doi: 10.1001/jama.2007.56-b.

PMID:
18182600
4.

Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.

Wu RR, Jin H, Gao K, Twamley EW, Ou JJ, Shao P, Wang J, Guo XF, Davis JM, Chan PK, Zhao JP.

Am J Psychiatry. 2012 Aug;169(8):813-21. doi: 10.1176/appi.ajp.2012.11091432.

PMID:
22711171
5.

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.

Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH.

Am J Psychiatry. 2008 Mar;165(3):352-8. doi: 10.1176/appi.ajp.2007.07010079. Epub 2008 Feb 1.

PMID:
18245179
6.

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.

Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, Hollway JA, Brian J, Arnold LE, Capano L, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, Hadjiyannakis S, Peleg N, Odrobina D, McAuliffe-Bellin S, Zakroysky P, Marler S, Wagner A, Wong T, Macklin EA, Veenstra-VanderWeele J.

JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232.

PMID:
27556593
7.

Management of atypical antipsychotic drug-induced weight gain: focus on metformin.

Miller LJ.

Pharmacotherapy. 2009 Jun;29(6):725-35. doi: 10.1592/phco.29.6.725. Review.

PMID:
19476423
8.

Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.

de Silva VA, Dayabandara M, Wijesundara H, Henegama T, Gunewardena H, Suraweera C, Hanwella R.

J Psychopharmacol. 2015 Dec;29(12):1255-61. doi: 10.1177/0269881115613519. Epub 2015 Oct 28.

PMID:
26510448
9.

Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.

Wang M, Tong JH, Zhu G, Liang GM, Yan HF, Wang XZ.

Schizophr Res. 2012 Jun;138(1):54-7. doi: 10.1016/j.schres.2012.02.021. Epub 2012 Mar 5.

PMID:
22398127
10.

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.

Baptista T, Martínez J, Lacruz A, Rangel N, Beaulieu S, Serrano A, Arapé Y, Martinez M, de Mendoza S, Teneud L, Hernández L.

Can J Psychiatry. 2006 Mar;51(3):192-6.

PMID:
16618011
11.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
12.

A systematic review of metformin to limit weight-gain with atypical antipsychotics.

Lee YJ, Jeong JH.

J Clin Pharm Ther. 2011 Oct;36(5):537-45. doi: 10.1111/j.1365-2710.2011.01255.x. Epub 2011 Mar 21. Review.

PMID:
21418264
14.

Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.

Carrizo E, Fernández V, Connell L, Sandia I, Prieto D, Mogollón J, Valbuena D, Fernández I, de Baptista EA, Baptista T.

Schizophr Res. 2009 Aug;113(1):19-26. doi: 10.1016/j.schres.2009.05.007. Epub 2009 Jun 9. Erratum in: Schizophr Res. 2009 Nov;115(1):96.

PMID:
19515536
15.

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

Worsley R, Jane F, Robinson PJ, Bell RJ, Davis SR.

Climacteric. 2015 Apr;18(2):270-7. doi: 10.3109/13697137.2014.954997. Epub 2014 Oct 21.

PMID:
25333776
16.

Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.

Zheng W, Li XB, Tang YL, Xiang YQ, Wang CY, de Leon J.

J Clin Psychopharmacol. 2015 Oct;35(5):499-509. doi: 10.1097/JCP.0000000000000392.

PMID:
26280837
17.

Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.

Derosa G, Mereu R, Salvadeo SA, D'Angelo A, Ciccarelli L, Piccinni MN, Ferrari I, Gravina A, Maffioli P, Cicero AF.

Intern Med. 2009;48(5):265-71. Epub 2009 Mar 2.

19.
20.

Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.

Praharaj SK, Jana AK, Goyal N, Sinha VK.

Br J Clin Pharmacol. 2011 Mar;71(3):377-82. doi: 10.1111/j.1365-2125.2010.03783.x. Review.

Supplemental Content

Support Center